← FDA Drug Approvals (Drugs@FDA)
AMLODIPINE BESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2026-09-22
Drug application
- FDA Application #
ANDA210489
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMLODIPINE BESYLATE
- Generic name
- Amlodipine Besylate
- Active ingredients
- AMLODIPINE BESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- IPCA LABS LTD
- First approval
- 2026-09-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown